课题基金 / 基金详情

Innate immune parameters leading to virus-induced secondary bacterial pneumonia and sepsis.

Innate immune parameters leading to virus-induced secondary bacterial pneumonia and sepsis.
先天免疫参数导致病毒诱发的继发性细菌性肺炎和败血症。
批准号:
G0802752/1
负责人:
Tracy Hussell
金额:
$75.83万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2010
资助国家:
英国
项目状态:
已结题
起止时间:
2010 至 --

项目摘要

项目成果

Tracy Hussell的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Influenza virus causes significant illness and death annually, which drives the development of vaccines for those most at risk. However, it is not widely appreciated that influenza does not always act alone. In combination with bacteria, this viral disease is much worse and the prognosis poor. This is not simply a problem with seasonal influenza virus strains. Recently, researchers have re-analysed specimens taken from those that died during the most severe pandemics and revealed a plethora of bacterial species. In a large proportion multiple bacterial species were present. Why do they cause a problem in some influenza infected individuals and not others? We believe that an individuals past infection history and consequent status of immune cell activity are responsible. We have evidence that influenza alters the activity of key anti-bacterial immune cells in the lower airways rendering them un-responsive to bacteria where they expand and cause pneumonia. We will now dissect this effect to gain a better understanding of the full complexities of this combined infectious disease. Such analysis may identify critical pathways that allow this virus-induced bacterial problem to occur in the first place, which will assist in the identification of those most at risk and potential avenues for targeted treatment. We will also analyse the impact of antibiotics that have different modes of action since it is clear that some strategies result in a worse outcome. The research will provide a possibility for better informed patient management in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Capacity building in single cell inflammation discovery: developing the next generation of scientists
  • 批准号:
    MC_PC_15072
  • 项目类别:
    Intramural
  • 资助金额:
    $95.57万
  • 财政年份:
    2016
  • 负责人:
    Tracy Hussell
  • 依托单位:
国内基金
海外基金
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
  • 批准号:
    82371973
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    孙迪
  • 依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
  • 批准号:
    82371798
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    叶俊娜
  • 依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
  • 批准号:
    82371141
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈颖
  • 依托单位:
CD27-CD28-CD8+T细胞调控儿童肝脏移植免疫耐受形成的作用和机制
  • 批准号:
    82371791
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    刘永波
  • 依托单位: